Skip to content

Controlled human cross-over intervention trial to demonstrate the bioactivity of Tropaeolum majus (nasturtium) - pilot study

Controlled human cross-over intervention trial to demonstrate the bioactivity of Tropaeolum majus (nasturtium) - pilot study - Tropaeolum Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00016548
Enrollment
41
Registered
2019-01-14
Start date
2019-03-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

health promoting potential Healthy volunteers

Interventions

Group 1: Nasturtium, active preparation (BITC-containing) for 14 days (2 times daily), special diet during washout (7 days before intervention) and during the intervention phase. Group 2: Nasturtium,

Sponsors

Universitätsklinikum FreiburgInstitut für Infektionsprävention und KrankenhaushygieneMolekulare Präventivmedizin
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: healthy, non-smokers

Exclusion criteria

Exclusion criteria: acute and chronic diseases, acute peptic ulcer, acute nephritis, pregnancy, breastfeeding, taking antibiotics (acute, during the last three months), known allergy to Cruciferous vegetables and BMI> 25 or <18.5

Design outcomes

Primary

MeasureTime frame
anti-inflammatory potential of nasturtium, before and after intervention, by PGE2 measurement in the blood and peripheral immune cells, which are isolated from blood with and without stimulation in vitro.

Secondary

MeasureTime frame
Alteration of inflammatory markers in the respiratory air condensate, modification of the composition of the gut microbiota (totality of colonizing microorganisms), release of signaling molecules, and the determination of BITC / metabolites and other phytochemicals before and after the intervention.

Countries

Germany

Contacts

Public ContactCorinna Herz

Universitätsklinikum Freiburg, Institut für Infektionsprävention und KrankenhaushygieneMolekulare Präventivmedizin

corinna.herz@uniklinik-freiburg.de07641 270 83010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026